Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back
- PMID: 20014119
- PMCID: PMC4051786
- DOI: 10.1002/ajmg.a.33183
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back
Abstract
The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.
Similar articles
-
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.Am J Med Genet A. 2015 Jan;167A(1):1-10. doi: 10.1002/ajmg.a.36793. Epub 2014 Nov 12. Am J Med Genet A. 2015. PMID: 25393061 Free PMC article.
-
Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.Am J Med Genet A. 2018 Dec;176(12):2924-2929. doi: 10.1002/ajmg.a.40632. Epub 2018 Oct 10. Am J Med Genet A. 2018. PMID: 30302932 Free PMC article.
-
The RASopathies.Annu Rev Genomics Hum Genet. 2013;14:355-69. doi: 10.1146/annurev-genom-091212-153523. Epub 2013 Jul 15. Annu Rev Genomics Hum Genet. 2013. PMID: 23875798 Free PMC article. Review.
-
First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.Am J Med Genet A. 2019 Jun;179(6):1091-1097. doi: 10.1002/ajmg.a.61125. Epub 2019 Mar 25. Am J Med Genet A. 2019. PMID: 30908877 Free PMC article.
-
A review of craniofacial and dental findings of the RASopathies.Orthod Craniofac Res. 2017 Jun;20 Suppl 1(Suppl 1):32-38. doi: 10.1111/ocr.12144. Orthod Craniofac Res. 2017. PMID: 28643916 Free PMC article. Review.
Cited by
-
The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.Am J Med Genet A. 2012 Sep;158A(9):2225-32. doi: 10.1002/ajmg.a.35535. Epub 2012 Jul 20. Am J Med Genet A. 2012. PMID: 22821737 Free PMC article. Review.
-
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.Am J Med Genet A. 2020 Apr;182(4):866-876. doi: 10.1002/ajmg.a.61485. Epub 2020 Jan 8. Am J Med Genet A. 2020. PMID: 31913576 Free PMC article.
-
Clinical Insights Into Heritable Cardiomyopathies.Front Genet. 2021 Apr 28;12:663450. doi: 10.3389/fgene.2021.663450. eCollection 2021. Front Genet. 2021. PMID: 33995492 Free PMC article. Review.
-
New Genetic Insights into Congenital Heart Disease.J Clin Exp Cardiolog. 2012 Jun 15;S8:003. doi: 10.4172/2155-9880.S8-003. J Clin Exp Cardiolog. 2012. PMID: 22822471 Free PMC article.
-
A generalizable pre-clinical research approach for orphan disease therapy.Orphanet J Rare Dis. 2012 Jun 15;7:39. doi: 10.1186/1750-1172-7-39. Orphanet J Rare Dis. 2012. PMID: 22704758 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials